MedPath

GWO XI STEM CELL APPLIED TECHNOLOGY CO., LTD.

🇹🇼Taiwan
Ownership
Public
Employees
-
Market Cap
-
Website
http://www.gwoxi.com.tw

An Open-labeled Phase II Study to Evaluate the Efficacy and Safety of GXNPC-1 in Patients With Chronic Stroke

Phase 2
Active, not recruiting
Conditions
Chronic Stroke
Interventions
First Posted Date
2019-09-12
Last Posted Date
2023-04-11
Lead Sponsor
Gwo Xi Stem Cell Applied Technology Co., Ltd.
Target Recruit Count
15
Registration Number
NCT04088149
Locations
🇨🇳

HualienTzu Chi Hospital, Hualien City, Taiwan

A Phase II Open-label Single-arm Study to Evaluate the Efficacy and Safety of ADSCs in Subjects With Liver Cirrhosis

Phase 2
Recruiting
Conditions
Liver Cirrhosis
Interventions
First Posted Date
2019-09-12
Last Posted Date
2023-04-10
Lead Sponsor
Gwo Xi Stem Cell Applied Technology Co., Ltd.
Target Recruit Count
20
Registration Number
NCT04088058
Locations
🇨🇳

HualienTzu Chi Hospital, Hualien City, Taiwan

🇨🇳

National Taiwan University Hospital, Taipei county, Taiwan

Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (GXCPC1) for Knee Osteoarthritis

Phase 1
Completed
Conditions
Knee Osteoarthritis
Interventions
Device: HA
First Posted Date
2019-05-09
Last Posted Date
2023-06-06
Lead Sponsor
Gwo Xi Stem Cell Applied Technology Co., Ltd.
Target Recruit Count
25
Registration Number
NCT03943576
Locations
🇨🇳

GWOXI Stem Cell Applied Technology Co., Ltd., Hsinchu, Taiwan

Clinical Trial Study About Human Adipose-Derived Stem Cells in the Stroke

Phase 1
Completed
Conditions
Stroke
Interventions
Drug: ADSCs
First Posted Date
2016-06-27
Last Posted Date
2018-12-07
Lead Sponsor
Gwo Xi Stem Cell Applied Technology Co., Ltd.
Target Recruit Count
3
Registration Number
NCT02813512
Locations
🇨🇳

Hualien Tzu Chi Hospital, Hualien city, Taiwan

🇨🇳

Gwo Xi Stem Cell Applied Technology Co., Ltd., Hsinchu, Taiwan

Clinical Trial Study About Human Adipose-Derived Stem Cells in the Liver Cirrhosis

Phase 1
Completed
Conditions
Liver Cirrhosis
Interventions
Drug: ADSCs
First Posted Date
2014-11-21
Last Posted Date
2018-04-17
Lead Sponsor
Gwo Xi Stem Cell Applied Technology Co., Ltd.
Target Recruit Count
6
Registration Number
NCT02297867
Locations
🇨🇳

China Medical University Beigang Hospital, Taichung, Beigang, Taiwan

🇨🇳

Gwo Xi Stem Cell Applied Technology Co., Ltd., Hsinchu, Taiwan

© Copyright 2025. All Rights Reserved by MedPath